Sun Pharma Advanced Research Company Limited (BOM:532872)

India · Delayed Price · Currency is INR

124.40

+4.05 (3.37%)

At close: Apr 2, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Pharmaceuticals Research and Development	717.66M	755.45M	2.39B	1.37B	2.53B
Pharmaceuticals Research and Development Growth	-5.00%	-68.36%	73.98%	-45.74%	229.31%
Total	717.66M	755.45M	2.39B	1.37B	2.53B
Total Growth	-5.00%	-68.36%	73.98%	-45.74%	229.31%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	700.82M	749.01M	1.07B	1.32B	2.41B
India Growth	-6.43%	-30.04%	-19.03%	-45.12%	246.06%
Outside India	16.84M	6.44M	1.32B	50.21M	120.02M
Outside India Growth	161.44%	-99.51%	2523.59%	-58.17%	67.00%
Total	717.66M	755.45M	2.39B	1.37B	2.53B
Total Growth	-5.00%	-68.36%	73.98%	-45.74%	229.31%

Source: S&P Global Market Intelligence.